Measles: The Vaccine Strain, or The Wild Strain?
Updated: 3 days ago

A systematic campaign is in motion to blame the unvaccinated for measles outbreaks. It is being used in real time to lay the groundwork for the most aggressive vaccine mandate architecture this country has seen. In Gaines County, Texas, a Mennonite community was named and blamed for the 2025 Southwest outbreak before the sequencing was even complete. In the medical press, the dominant framing is that declining MMR coverage is responsible for everything from case clusters to projected outbreaks “lasting up to a year.” Public health officials and corporate media outlets are coordinating the message with remarkable discipline: outbreaks are wild measles, unvaccinated people caused them, the solution is mandates.
The medical community is saying all of this while sitting on top of a mountain of evidence that complicates every piece of that narrative — including the CDC’s own historical mortality data, thirty years of peer-reviewed primary literature in their own journals, federal court records from a whistleblower case against the sole U.S. manufacturer of the MMR vaccine, the operating legal framework of the federal vaccine injury compensation program, and basic arithmetic about who is actually shedding measles virus into the environment that infants live in.
This piece walks the receipts. Every citation is hyperlinked. Full works cited at the bottom.
Before the three dismissals even enter the frame, a foundational myth has to be addressed — because the entire scare is built on top of it, and when the myth collapses the mandate case collapses with it.
Before The Dismissals: The Foundational Myth Underneath The Scare
The current measles scare rests on an unstated premise: that measles was a devastating killer of American children before the vaccine arrived in 1963, and that only the MMR stands between us and a return to those conditions. That premise is false on the CDC’s own historical data.
Measles mortality in the United States declined by over 98% BEFORE the measles vaccine was introduced in 1963.
This is not a contested claim on fringe websites. It is in the CDC’s own historical mortality records, confirmed in mainstream peer-reviewed population science literature, and it has been widely acknowledged in public health history for over fifty years. The seminal analysis — McKinlay and McKinlay, 1977 — concluded that at most 3.5% of the total decline in American mortality from infectious disease since 1900 could be attributed to specific medical measures including vaccines. The arithmetic has never been successfully refuted.
By the time the measles vaccine was licensed, the disease was overwhelmingly a self-limiting childhood illness. Alexander Langmuir — who was the CDC’s own Chief of Epidemiology during the period the vaccine was introduced — described measles in print as “a self-limiting infection of short duration, moderate severity, and low fatality.” That was the characterization offered by the CDC’s own epidemiology chief, in the medical literature of the era, at the moment of vaccine licensure. In the decade before the vaccine, approximately 400-500 deaths per year occurred against 3-4 million annual infections — a case fatality rate on the order of 1 in several thousand actual cases, and 1 in approximately 1,215 reported cases.
The pre-vaccine mortality decline was driven by things the mandate conversation never mentions: clean drinking water, modern sanitation, better housing, labor reforms that got children out of factories, electricity, refrigeration, food transportation, improved nutrition, and antibiotics that stopped children from dying of secondary bacterial pneumonia following measles infection. These were the interventions that made measles survivable. The vaccine, arriving in 1963, met a disease whose lethal edge had already been blunted by multiple decades of public health improvement that had nothing to do with vaccines.
And one specific nutritional factor stands out, because it has been documented by the World Health Organization itself.
The vitamin A intervention the medical community pushing mandates somehow never leads with
In 1990, Gregory Hussey and Max Klein published a landmark study in the New England Journal of Medicine on vitamin A supplementation in children with severe measles in Cape Town. The finding: vitamin A supplementation reduced measles mortality by 50% in children with severe measles. Subsequent systematic reviews and meta-analyses — including multiple Cochrane reviews — have confirmed and extended the finding. In vitamin-A-deficient populations, supplementation reduces measles mortality by 50 to 90 percent.
The World Health Organization currently recommends vitamin A supplementation for every child with a measles diagnosis, regardless of country of residence — 200,000 IU for children over 12 months, 100,000 IU for infants 6-11 months, administered on two consecutive days. This is WHO’s own standing recommendation. It is in the standard medical literature. It has been the WHO position for approximately four decades.
Ask your pediatrician what the first-line intervention for a child diagnosed with measles should be. A meaningful fraction of American pediatricians will not lead with vitamin A. Many will not mention it at all. The official pediatric response will frame mandate-compliance as the intervention, and omit entirely the simple, cheap, well-documented nutritional intervention that WHO has recommended for forty years and that cuts measles mortality by half or more.
The medical community that is pushing aggressive MMR mandates in the name of “protecting children from measles deaths” somehow never leads with vitamin A. If reducing child measles mortality were the actual priority, vitamin A sufficiency campaigns would be the first move in every state currently drafting mandate legislation. They are not even the fifth move. They are often not mentioned at all.
And the full nutritional picture is broader than vitamin A alone. The scientific literature on nutritional immunology supports a stack — vitamin A, vitamin C, vitamin D, and zinc — that together substantially reduces measles complication rates beyond what any single nutrient achieves alone. Vitamin C supports neutrophil function and recycles oxidized antioxidants in the immune response. Vitamin D sufficiency correlates with better outcomes across multiple viral respiratory conditions and modulates both innate and adaptive immunity. Zinc is required by well over 300 enzymes including those involved in immune cell maturation, and zinc deficiency is specifically associated with worse viral infection outcomes. The combined A + C + D + zinc stack addresses the nutritional foundation of resistance that the mandate framing entirely skips.
The full supportive-care supplementation protocol is laid out in The Measles Protocol, freely available on my website. The protocol is specifically designed to reduce the risk of complications in a diagnosed case and is accessible to any parent who wants to put in place what the medical establishment should have been leading with for decades and has not been.
The mandate scare operates by convincing the public that MMR compliance is the only meaningful tool between a child and a measles death. The CDC’s own historical mortality data, the WHO’s own vitamin A recommendation, and the broader nutritional immunology literature all say otherwise. The scare is built on the systematic non-mention of interventions that would make measles overwhelmingly survivable without requiring the mandate architecture at all.
Hold that foundation in mind as we walk the three dismissals. Everything that follows is being asserted against a backdrop where the disease being feared was already 98%+ non-lethal before the vaccine arrived, and where simple nutritional interventions could keep it that way without a single mandate.
There are three dismissals the medical community reliably offers whenever MMR vaccine shedding or outbreak attribution gets questioned:
The MMR vaccine cannot shed vaccine-strain virus.
The MMR vaccine cannot cause a vaccine-type measles infection.
The measles outbreaks you see in the news are wild-type outbreaks caused by unvaccinated people.
None of the three survives contact with the primary literature.
Claim One: “The MMR vaccine cannot shed vaccine-strain virus.”
This dismissal collapsed in 1995 when the CDC’s own researchers published it had happened. Rota PA, Khan AS, Durigon E, et al., writing in the Journal of Clinical Microbiology, used reverse-transcriptase PCR on urine from recently vaccinated 15-month-olds and young adults and detected vaccine-strain measles RNA in those samples. The paper is not retracted. It is sitting in PubMed, searchable, citable, since 1995.
What the CDC published once, independent international researchers kept finding. In 2010, Kaic et al. published in Eurosurveillance the case of a 14-month-old Croatian child who developed a measles rash and fever eight days after MMR vaccination. Testing confirmed vaccine-strain Schwarz measles virus in both the child’s pharyngeal secretions and urine, 2-4 weeks post-MMR. Not just urine shedding. Upper respiratory shedding — into the air the child was breathing out — of a measles virus the child had received in a needle two to four weeks before.
The duration numbers coming out of the literature are substantially longer than the public communication acknowledges. Vaccine-strain measles RNA has been detected in respiratory tract samples up to 784 days post-vaccination.
Over two years. In documented published cases.
And the Colorado Department of Public Health’s own wastewater surveillance program, publishing in the CDC’s MMWR in August 2025, describes its protocol in a sentence that does more work than public health probably intended: “Wastewater surveillance is conducted for both wild-type (highly contagious) and vaccine-derived measles (weakened strain in the measles, mumps, and rubella vaccine).”
Read that again. The CDC’s own wastewater surveillance protocol openly acknowledges that vaccine-derived measles is shed into community wastewater in detectable quantities, requiring active monitoring to distinguish it from wild-type. That is not a contested claim on fringe websites. That is a description of standard practice in a CDC journal, dated 2025.
This is the architecture of the disclosure failure in miniature. In the technical literature where other scientists read it, vaccine-derived measles shedding is acknowledged and actively surveilled. In the public communication parents receive at the pediatrician’s office, it does not exist. The information is not missing. The information is openly published — and openly ignored.
When your pediatrician tells you MMR cannot shed, your pediatrician is either unaware of thirty years of their own agency’s published findings, or aware and choosing not to say so. Both possibilities should concern you. They should concern you more because the mandate architecture being built right now is built on the public-communication version of this story, not the published-literature version.
The verdict on Claim One: [Tier 1 — Documented]. Vaccine-strain shedding from the MMR has been documented since 1995, in multiple body-fluid compartments, by the CDC itself, and is actively surveilled in community wastewater by public health today. The dismissal is false on the primary literature. It is also false on the CDC’s own current operational practices.
Claim Two: “The MMR vaccine cannot cause a vaccine-type measles infection.”
The second dismissal concedes that some RNA may be detectable after vaccination while insisting this detection does not represent actual infection, does not produce disease, and cannot be mistaken clinically for wild measles. All three of those concessions are contradicted by published case reports — and by the federal government’s own vaccine injury compensation regulation.
Murti et al. 2013, published in Eurosurveillance, documented a British Columbia case in which a vaccinated person tested positive for measles by both PCR and IgM antibody testing five weeks after MMR vaccination. Both diagnostic criteria for a confirmed measles infection were met. The organism was identified as the vaccine strain. The authors, in their published conclusion, explicitly called for extended surveillance using modern PCR sensitivity because the assumed timeframe for vaccine-virus shedding and illness is too narrow. That call, made in 2013, has been ignored for twelve years running.
Nagai et al., publishing in Pediatric Infectious Disease Journal, described a DiGeorge syndrome patient on TNF-inhibitor therapy who developed a measles rash following MMR vaccination. Vaccine-strain Edmonston genotype A measles virus was isolated directly from the skin scrapings of the rash itself. The clinical presentation was indistinguishable from wild measles. Only the genotyping distinguished them.
Bitnun et al. 1999 published a case of measles inclusion-body encephalitis caused by the vaccine strain of measles virus — a serious neurological complication, genetically confirmed as vaccine-origin, published 27 years ago.
So the three sub-claims under Claim Two collapse: vaccine-strain shedding DOES represent actual infection (meeting both PCR and IgM criteria), it CAN produce clinical disease (rash illness, encephalitis), and it IS mistaken for wild measles without genotyping.
Now here is where the dismissal doesn’t just fall apart — it detonates.
The federal regulation that legally presupposes what the public communication denies
Pull up 42 CFR Part 100 — the Vaccine Injury Compensation Program regulation. Section 100.3 defines the Vaccine Injury Table — the list of injuries that qualify for federal compensation under the National Vaccine Injury Compensation Program. Measles-containing vaccines are on that table. Encephalopathy and encephalitis following MMR administration are table-recognized injuries.
But read what the regulation itself says about strain determination:
“If strain determination reveals wild-type measles virus or another, non-vaccine-strain virus, the disease shall not be considered to be a condition set forth in the Table.”
Think through what this sentence is doing. The regulation is telling you that when a measles infection follows MMR vaccination closely enough in time to raise injury compensation questions, the government needs to determine the strain. If the strain is wild-type, it wasn’t the vaccine — not a compensable injury. If the strain is vaccine-origin, the Table applies — compensable injury.
The entire regulatory architecture of the Vaccine Injury Table presupposes that vaccine-strain measles infections occur, cause recognizable disease, and warrant federal compensation when they do. The regulation would be meaningless otherwise. The sentence “if strain determination reveals wild-type” would have no reason to exist if the alternative — strain determination revealing vaccine-type — were not a routine possibility the law had to contemplate.
And the compensation numbers prove this is not theoretical. The National Vaccine Injury Compensation Program’s own official HRSA statistics through January 2025 show 1,070 MMR injury petitions filed, with 439 compensated. That’s a 41% compensation rate on MMR injury claims — a program operating with notoriously high evidentiary bars, awarding compensation nearly half the time an MMR injury petition is filed. A single MMR brain-injury case received $101 million in compensation. Over the life of the program, the VICP has paid out approximately $5.3 billion in total compensation for vaccine injuries across all covered vaccines and VAERS itself has admitted it captures under 1% of adverse events.
The medical establishment’s public position: the MMR vaccine cannot cause a vaccine-type measles infection.
The federal government’s legal position, as encoded in binding regulation: vaccine-strain measles infections following MMR are compensable injuries, and you need genotyping to determine whether a given case qualifies.
Both of these cannot be true. One of them is the published federal regulation and the operating framework of a $5.3 billion program. The other is what your pediatrician tells you to reassure you.
The verdict on Claim Two: [Tier 1 — Documented, reinforced by federal regulatory language and active injury compensation data]. The dismissal is contradicted by published case reports in mainstream peer-reviewed journals AND by the operating legal framework of the National Vaccine Injury Compensation Program.
Claim Three: “The measles outbreaks you see in the news are wild-type outbreaks caused by unvaccinated people.”
This is the dismissal the current measles scare is built on. It is the dismissal underwriting every mandate push now making its way through state legislatures. The honest answer is more damning than a flat denial would be.
The World Health Organization’s recommended protocol for distinguishing vaccine-strain from wild-type measles requires sequencing the 450-nucleotide N-450 region of the viral nucleoprotein gene. The reason the protocol works is biology: all measles vaccine strains in use worldwide belong to a single genotype — genotype A — because they were all derived from the Edmonston strain isolated in the 1950s. Wild-type circulating strains belong to other genotypes — D4, D8, B3, H1. N-450 sequencing reads the viral nucleoprotein gene and classifies the sample by genotype, immediately telling you whether you are looking at vaccine-origin or wild virus.
This is on the public record in the standard laboratory reference LOINC 88875-0: “Vaccine strains all belong to genotype A.”
The problem is that standard measles PCR used in routine public health diagnosis does not distinguish vaccine from wild-type. It detects measles virus. It does not sequence the N-450 region. Unless a lab specifically performs the discriminating sequencing, a positive PCR result carries zero information about whether the virus is vaccine-derived or wild-type. A faster vaccine-strain-specific real-time PCR exists — the MeVA assay — but has published sensitivity of approximately 94%. It misses approximately 6% of vaccine-strain cases even when it is run. And in the United States, neither the MeVA assay nor full N-450 sequencing is routinely performed at the scale necessary to resolve the question nationally.
What happens when the sequencing IS done
In 2017, Rota JS, Hiebert J, Severini A, et al. published a paper in the CDC’s own flagship journal Emerging Infectious Diseases titled “Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.” Canada’s National Microbiology Laboratory sequenced 33 cases from a single outbreak cluster using WHO-recommended N-450 methodology. The exact sentence from the paper:
“NML identified wild-type virus in 17 of 33 persons and genotype A vaccine strain by conventional N-450 sequencing in the remaining 16.”
Nearly half the sequenced cases — 16 of 33 — were vaccine-strain, not wild-type measles. In one outbreak. Published in the CDC’s own journal. Based on an investigation performed only because Canada’s NML ran the sequencing that no one in the United States is required to run. It has not changed American public health communication practice or outbreak reporting conventions in the eight years since publication.
The 2025 Texas outbreak — honest framing sharpens the point
Texas 2025 WAS sequenced, more thoroughly than most recent American outbreaks. The CDC’s MMWR April 2025 update reports that 251 cases out of the initial outbreak had specimens available for sequencing, and all sequenced specimens were confirmed wild-type genotype D8 or B3. That looks, at first glance, like a clean counter-example to the surveillance-gap argument. It is not.
First: Even in this unusually well-sequenced outbreak, only 31% of total cases had specimens available for molecular sequencing. 69% of cases were never sequenced. Among the unsequenced 69%, any vaccine-strain fraction present in the outbreak remained invisible.
Second: The sequencing that was performed used methods subject to the Hatchette 2025 vulnerability we will walk in the next section — the MeVA vaccine-strain-specific PCR has documented false-negative potential on mutated vaccine strains.
Third: The 2025 outbreak in Gaines County, Texas, was publicly attributed to the under-vaccinated Mennonite community weeks before the sequencing results were in. Yale’s April 2025 risk assessment and essentially every mainstream press report named the Gaines County under-vaccination rate as the cause of the outbreak before the molecular surveillance could possibly have determined the origin of the index case. The epidemiological narrative preceded the data. The outbreak was being used politically to argue for expanded vaccine mandates in Texas and neighboring states while the actual sequencing was still underway.
This is the exact pattern Gaines County residents warned about. The story was already written before the data existed. That is the mandate-escalation architecture, in miniature, in real time.
The verdict on Claim Three: [Tier 1 — Documented for the specific case of Ontario 2015; Contested for the general proportion across all unsequenced outbreaks, with the contested status being a direct consequence of the systematic under-performance of discriminating surveillance].
Fully Vaccinated People Catch And Transmit Measles. The Mandate Case Depends On You Not Knowing This.
The three dismissals above assume that even when they fail at the edges, the broader mandate logic survives: vaccinated people are protected, unvaccinated people are the vectors, so mandating the unvaccinated protects everyone. The published record says this framing is false. The vaccinated catch measles, the vaccinated transmit measles, and in the specific population most often cited as the reason mandates are urgent — infants too young to vaccinate — the dominant source of measles-virus exposure is almost certainly the recently vaccinated, not the unvaccinated.
The Rosen 2014 “Measles Mary” case
In 2011, a 22-year-old theater employee in New York City — fully vaccinated with both documented doses of MMR — contracted measles. Rosen JB, Rota JS, Hickman CJ, et al., publishing in Clinical Infectious Diseases in 2014, documented the full investigation. Of 88 contacts she had while symptomatic, 4 developed measles. Two of those four secondary cases were also fully vaccinated with both doses.
Confirmed by Science news coverage as the first documented case of measles transmission from a twice-vaccinated individual. Her IgM response looked like primary infection — her immune system responded as if it had never been vaccinated.
This single paper destroys two claims that are load-bearing for the entire mandate case:
“Fully vaccinated people cannot catch measles.” The Rosen patient caught measles despite two documented doses.
“Even if a rare vaccine failure catches it, they cannot transmit measles.” She transmitted to four contacts. Two were fully vaccinated.
And it is not an isolated finding. The 2014 Netherlands healthcare worker outbreak (Hahné et al., Journal of Infectious Diseases) documented an outbreak among 8 previously-immunized healthcare workers — 6 of them twice-vaccinated. The broader review literature confirms that “increasing numbers of measles cases are occurring among fully vaccinated, seropositive individuals.”
There is even a basic mathematical point here that the public conversation never acknowledges: as vaccination coverage increases, the proportion of measles cases occurring in fully-vaccinated individuals mathematically increases, not decreases. At theoretical 100% coverage, 100% of measles cases would by definition be in the vaccinated. The “most outbreak cases are in unvaccinated people” framing becomes less defensible, not more, as coverage rises — which is the exact opposite of what public health communication implies.
The exposure-source inversion — the mandate’s own logic turned inside out
Now walk the arithmetic of who is actually likely to be shedding measles virus near an American infant on any given day.
Approximately 4 million MMR doses are administered to American children each year, as part of the two-dose childhood schedule. Add adult boosters, pre-outbreak campaign surges, and healthcare-worker booster programs, and the total doses administered annually likely exceeds 5 million. Every recent recipient is, by the documented evidence walked in Claim One above, actively shedding vaccine-strain measles virus — in urine for up to two weeks, in respiratory secretions potentially longer, out to 784 days post-vaccination in some documented cases.
Against that: in a typical recent year prior to the current scare, the United States has recorded dozens to low hundreds of wild measles cases. Even the 2025 Southwest outbreak at approximately 800 cases is a statistical outlier. A wild-measles case is symptomatic for roughly a week; a vaccine-strain shedding window spans weeks to months.
Do the math.
At any given moment, the pool of people in the United States actively shedding vaccine-strain measles RNA is at minimum thousands of times — and more likely tens of thousands of times — larger than the pool of people actively infected with and shedding wild-type measles.
Now add the population consideration that mandate advocates lead with: infants under 12 months are the group that cannot receive the MMR vaccine, is medically most vulnerable to measles complications, and is almost always surrounded by recently-vaccinated older siblings, cousins, visiting adults, and family members. The infant’s actual measles-virus exposure environment is dominated, statistically, by vaccine-strain shedders — not by wild-infected contacts.
The “mandate the unvaccinated to protect the infants through herd immunity” argument, which is the single most emotionally powerful piece of mandate rhetoric, has an inversion problem its advocates have never addressed.
The actual dominant source of measles-virus exposure to American infants in any typical year is almost certainly recently-MMR-vaccinated contacts, not people actively infected with wild measles — because the recently-vaccinated outnumber wild-infected by many orders of magnitude.
This is not an accusation against vaccinated individuals. Most people who take the MMR vaccine do so because they genuinely want to protect others — including infants. The point here is gentler and sadder: the framework they were sold is inverted. They were told that by getting vaccinated they would be contributing to herd protection of vulnerable infants. The documented reality, taken together, is that they may be contributing more measles virus to the environment those infants live in than they would have as unvaccinated adults living their lives with no measles infection.
That is not their fault. They were doing what they were told was the right thing. But the right thing, when the underlying biology is honestly accounted for, may look substantially different than what the public health framing claims. The research to measure infant exposure rates to vaccine-strain versus wild-type measles has not been commissioned. It would not be hard to run. It is not being run — because the result would, in all likelihood, invert the moral architecture of the entire mandate conversation.
The verdict on this section: [Tier 1 Documented for the shedding data and the Rosen transmission finding; Tier 2 Logical Inference for the infant-exposure inversion, with the inference being unavoidable on the published numbers and the research to resolve it demonstrably not being pursued.]
The 2025 Finding That Compounds Everything
In 2025, Hatchette TF, Haldane D, et al. published a case — again in Ontario — under the title “Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test.”
The case: a vaccinated child developed a self-limited rash illness after MMR. N-450 sequencing confirmed vaccine-strain. But the rapid MeVA vaccine-strain-specific PCR assay — the standard screening test labs use to flag vaccine origin quickly — produced a false negative. The vaccine virus had mutated slightly from the reference sequence, enough that the MeVA primers and probe no longer matched it. The assay failed to detect that the virus was vaccine-derived.
Think through the implication. The lab tool the system relies on to rapidly screen cases for vaccine origin can produce false negatives on mutated vaccine strains. In any outbreak where the MeVA assay is being used instead of full N-450 sequencing (and the MeVA is faster, cheaper, more routine), a mutated vaccine-strain case can be screened negative for vaccine origin and then logged as part of the wild-type outbreak.
The direction of the error is not neutral. It biases the entire surveillance system toward under-counting vaccine-strain cases and over-counting wild-type cases. Published 2025. In the peer-reviewed record. Confirming that even the “rapid screening” infrastructure the public health system relies on has a documented vulnerability that happens to tilt in exactly the direction the official narrative requires.
Nobody in American public health communication is naming this vulnerability. Nobody is correcting the Texas 2025 outbreak surveillance to account for it. The paper exists. It sits there. The silence around it is the story.
The Merck Court Record — Why These Dismissals Cannot Be Taken At Face Value
If this were the only area of concern around the MMR, the dismissals might carry a presumption of good faith. They do not, because the manufacturer whose product and whose data the entire dismissal apparatus depends on has an established federal court record of data manipulation in exactly this product line.
In 2010, two senior Merck virologists — Stephen Krahling and Joan Wlochowski — filed a qui tam whistleblower lawsuit under the False Claims Act against their former employer. The case, United States ex rel. Krahling v. Merck & Co., was filed under seal in 2010 and unsealed in 2012. The relators alleged, from firsthand knowledge of the lab operations, that Merck had deliberately falsified efficacy testing of the mumps component of the MMR II vaccine to maintain its FDA-registered claim of 95% efficacy.
Among the specific practices alleged and documented in court filings:
Testing against the vaccine strain of mumps instead of the wild mumps virus — meaning the efficacy test was rigged to produce artificially high results that would not hold against the actual circulating mumps strains in the field
“Overfilling” vaccine doses with excess live virus to meet efficacy targets — not a disclosed practice, not safety-tested at the elevated viral loads, used to make the arbitrary 95% efficacy number
Destruction of evidence and misrepresentation to an FDA investigator
Threats of imprisonment directed at a Merck vaccine-division virologist who considered reporting the fraud
The court record acknowledges — not disputes, acknowledges — that Merck “sought to extend its apparent monopoly by misrepresenting facts about its mumps vaccines on FDA-approved labeling.”
The 2024 Third Circuit Court of Appeals affirmed dismissal of the case — not on the grounds that the fraud didn’t occur, but on the narrower technical grounds that the plaintiffs did not prove the fraud was material to the United States government’s decision to purchase MMR. In other words: “yes, the fraud happened, but we are dismissing because the government would have bought the vaccine anyway.” The court effectively granted Merck a pass on documented data manipulation on the basis that the regulatory system was never going to act on the manipulation regardless.
The MMR vaccine is manufactured by a company with a federal court record of falsifying efficacy data on this specific product, documented by two of their own senior virologists, with evidence destruction and witness intimidation entered into the record. Every mainstream dismissal of MMR shedding, MMR-caused infection, or MMR outbreak misattribution originates from — or is reinforced by — data provided by this same manufacturer. The court record says the manufacturer’s data on this specific product has already been established as unreliable.
When the pediatrician tells you “the MMR cannot shed” or “cannot cause infection” or “is 95% effective against mumps,” the pediatrician is reciting what the manufacturer told the FDA — which a federal court has acknowledged contains documented falsification in at least one component of the product. Any informed-consent conversation about MMR that ignores this context is operating on less than the full picture a reasonable person would require.
What This Means for the Data — and for the Mandate Architecture
Every statistic the public health system uses to argue for continued or expanded MMR mandates is built on top of this architecture: surveillance that systematically under-detects vaccine-strain cases, diagnostic tools that have documented vulnerabilities biased in the direction of the official narrative, outbreak reporting conventions that presume wild-type origin without sequencing, a manufacturer with a federal court record of falsification in this product, infant-exposure arithmetic that inverts the “protect the vulnerable” framing, and a pre-vaccine mortality decline that the mandate case silently depends on parents not knowing about.
The downstream consequences, each of which has been building in the public case for mandates for decades:
Public measles case counts systematically over-represent wild-type measles. Every vaccine-strain case classified as wild-type in an unsequenced outbreak adds a false point to the “wild measles is returning” count that drives mandate advocacy.
Vaccine effectiveness estimates are inflated by the same mechanism. When a measurable fraction of apparent vaccine failures (vaccinated people appearing to catch measles) are actually vaccine-strain illnesses in those same vaccinated people, the standard effectiveness calculation is comparing categories that have been silently contaminated.
Outbreak attribution narratives rest on an assumption that is not only unverified but structurally un-verifiable with current surveillance practices. Gaines County Mennonites get blamed before the sequencing comes back. The political momentum captures the mandate case before the data could falsify the story even in principle.
Vaccine mandate legislation is being built on these inflated counts, inflated effectiveness estimates, inverted outbreak attributions, and an inverted infant-exposure premise. Removal of religious exemptions. Removal of philosophical exemptions. Employment-tied mandate enforcement. School attendance conditioned on compliance. Travel restrictions. The current measles scare is being deployed, right now, as the political justification for all of this.
And it is being deployed using surveillance data that, by the structural failures documented above, cannot resolve the questions it is being cited to resolve. That is not a technical point. That is a civil liberties emergency being set up in slow motion, built on top of a scare that the CDC’s own historical mortality data says never had the empirical foundation the mandate case attributes to it in the first place.
The Pattern, and the Silence That Should Alarm You
Every finding walked in this piece is in the published, mainstream, peer-reviewed scientific literature, or in the CDC’s own historical mortality data, or in the WHO’s own standing clinical recommendations, or in federal regulatory text, or in federal court records. None of this is hidden. None of this is contested fringe material. It is openly published and openly ignored.
The research to resolve every remaining uncertainty is empirically straightforward. Routine N-450 sequencing of every suspected measles case in the United States. Public outbreak reports with wild-vs-vaccine breakdowns. A rebuild of the MeVA rapid-screening assay to account for documented mutation-driven false negatives. An independent audit of Merck’s MMR efficacy data by an entity not dependent on Merck’s cooperation. A study of actual infant exposure rates to vaccine-strain versus wild-type measles. A national vitamin A sufficiency campaign that would address a huge fraction of measles mortality risk at a tiny fraction of the political and civil-liberties cost of mandate escalation.
None of this is being done at the scale the data requires. Not because it cannot be done. Not because the methodology is unclear. Because the system that produces the public communication is not disposed to generate data that would complicate it. A sequencing program of the kind this situation requires would almost certainly produce findings that embarrass the mandate narrative. A vitamin A sufficiency campaign would make it visible that the MMR mandate case rests on a disease that is overwhelmingly survivable with simple nutritional support. A study of infant exposure sources would almost certainly invert the “protect the vulnerable” argument. The system that benefits from the current narrative is not going to commission the research that would dismantle it.
This highlights the problem. It is not a conspiracy in the sense people reach for that word. It is a set of institutional incentives functioning exactly as they were designed to function — to protect the product, protect the manufacturer, protect the mandate pipeline, and protect the political capital of the public health establishment. The casualty is the parent, the physician, the legislator, and the journalist trying to think honestly about what is actually happening — and the countless Americans whose medical decisions and legal freedoms are being structured around data that cannot tell them what they are being told it is telling them.
The scare is manufactured. The pre-vaccine mortality decline is in the CDC’s own records. The vitamin A intervention that WHO recommends is unmentioned in the mandate case. The sequencing that would complicate outbreak attribution is not being done. The manufacturer whose product underwrites the whole conversation has a federal court record of data falsification. The federal government’s own injury compensation program legally presupposes the phenomenon the public communication denies. Fully vaccinated people catch and transmit measles, including to other fully vaccinated people. And the infants the mandates are being pushed to protect are almost certainly surrounded by more vaccine-strain measles virus than wild-type measles virus, because the recently-vaccinated outnumber the wild-infected by many orders of magnitude.
The mandate escalation this is all being used to justify will, if it proceeds, injure a lot of people who were never shown the record.
This piece is the record. Share it with anyone who needs to see it.
Works Cited
Bitnun A, Shannon P, Durward A, et al. “Measles inclusion-body encephalitis caused by the vaccine strain of measles virus.” Clinical Infectious Diseases. 1999;29(4):855-861.
Centers for Disease Control and Prevention. “Measles Update — United States, January 1-April 10, 2025.” Morbidity and Mortality Weekly Report. 2025;74(14). https://www.cdc.gov/mmwr/volumes/74/wr/pdfs/mm7414a1-H.pdf
Code of Federal Regulations, Title 42, Chapter I, Subchapter J, Part 100 — Vaccine Injury Compensation. https://www.ecfr.gov/current/title-42/chapter-I/subchapter-J/part-100
Colorado Department of Public Health. “Notes from the Field: Wastewater Surveillance for Measles Virus During a Measles Outbreak — Colorado, August 2025.” MMWR. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12806976/
Hahné SJM, Nic Lochlainn LM, van Burgel ND, et al. “Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.” Journal of Infectious Diseases. 2016;214(12):1980-1986.
Hatchette TF, Haldane D, et al. “Measles vaccine virus mutation following vaccination in a healthy child resulting in a false negative vaccine specific PCR test: Ontario, Canada, 2025.” 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12579314/
Health Resources and Services Administration. “National Vaccine Injury Compensation Program Data & Statistics.” January 2025. https://www.hrsa.gov/sites/default/files/hrsa/advisory-committees/vaccines/vicp-stats-01-01-25.pdf
Hiebert J, Zubach V, Charlton CL, et al. “Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR.” Journal of Clinical Microbiology. 2017;55(3):735-743. https://journals.asm.org/doi/10.1128/jcm.01879-16
Hussey GD, Klein M. “A randomized, controlled trial of vitamin A in children with severe measles.” New England Journal of Medicine. 1990;323(3):160-164.
Kaic B, Gjenero-Margan I, Aleraj B, et al. “Spotlight on measles 2010: Excretion of vaccine strain measles virus in urine and pharyngeal secretions of a child with vaccine-associated febrile rash illness, Croatia, March 2010.” Eurosurveillance. 2010;15(35):19652. https://www.eurosurveillance.org/content/10.2807/ese.15.35.19652-en
LOINC 88875-0 — “Measles virus genotype A vaccine strain N gene [Presence] in Specimen by NAA with probe detection.” https://loinc.org/88875-0
McKinlay JB, McKinlay SM. “The questionable contribution of medical measures to the decline of mortality in the United States in the twentieth century.” Milbank Memorial Fund Quarterly, Health and Society. 1977;55(3):405-428.
mctlaw. “MMR Vaccine Injuries — $101 Million Case Award.” https://www.mctlaw.com/vaccine/mmr-vaccine/
Murti M, Krajden M, Petric M, et al. “Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013.” Eurosurveillance. 2013;18(49):20649. https://www.eurosurveillance.org/content/10.2807/1560-7917.ES2013.18.49.20649
Nagai T, Okafuji T, Miyazaki C, et al. “Measles Vaccine Strain Genotype A from the Skin Rash of a DiGeorge Patient on a TNF Inhibitor.” Pediatric Infectious Disease Journal. https://pmc.ncbi.nlm.nih.gov/articles/PMC4385583/
Rosen JB, Rota JS, Hickman CJ, et al. “Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.” Clinical Infectious Diseases. 2014;58(9):1205-1210. https://pubmed.ncbi.nlm.nih.gov/24585562/
Rota JS, Hiebert J, Severini A, et al. “Measles Outbreak with Unique Virus Genotyping, Ontario, Canada, 2015.” Emerging Infectious Diseases (CDC journal). 2017;23(7). https://wwwnc.cdc.gov/eid/article/23/7/16-1145_article
Rota PA, Khan AS, Durigon E, et al. “Detection of measles virus RNA in urine specimens from vaccine recipients.” Journal of Clinical Microbiology. 1995;33(9):2485-2488. https://pubmed.ncbi.nlm.nih.gov/7494055/
United States ex rel. Krahling v. Merck & Co., Civil Action No. 10-4374 / 12-3555, E.D. Pa. https://case-law.vlex.com/vid/united-states-ex-rel-890323416
United States ex rel. Krahling v. Merck & Co., Third Circuit Court of Appeals dismissal, August 2024. https://advocatz.com/2024/08/14/whistleblower-case-against-merck-over-mmr-vaccine-dismissed/
World Health Organization. “Measles” fact sheet and vitamin A supplementation guidance. https://www.who.int/news-room/fact-sheets/detail/measles
Oshien A. The Measles Protocol (full supplementation framework). Freely available at adamoshien.com.
Yale School of Public Health Virtual Media Office of Communications. “Measles Outbreak Southwest US — Special Report.” April 2025. https://yalehealth.yale.edu/sites/default/files/2026-02/ysph%20vmoc%20special%20report%20-%20measles%20outbreak%20%20southwest%20us%204-12-2025%202300%20hrs%20vers2.pdf
About the author: Adam Oshien has worked in informed-consent education for over fourteen years. He is the author of I’m In Your Vaccines, The Measles Protocol, Wired for Struggle, and The Case Against Circumcision. His writing lives at adamoshien.com.



Comments